Examkin

Soru

Zorluk: ZorGastroenterology and Hepatology

Match each characteristic clinical presentation with the most likely corresponding gastrointestinal or pancreatic neuroendocrine tumor.

  • A 54-year-old woman with voluminous watery diarrhea, profound muscle weakness, a serum potassium of 2.1 mEq/L2.1 \text{ mEq/L}, and achlorhydria on gastric analysis.VIPoma
  • A 60-year-old man with weight loss, new-onset mild diabetes mellitus, and a pruritic, blistering erythematous rash with central clearing on his groin and lower extremities.Glucagonoma
  • A 45-year-old man with recurrent facial flushing, episodic crampy abdominal pain, chronic diarrhea, and a new holosystolic murmur best heard at the left lower sternal border.Carcinoid tumor
  • A 38-year-old woman with a history of recurrent nephrolithiasis and hypercalcemia who now presents with persistent dyspepsia and multiple peptic ulcers distal to the duodenal bulb.Gastrinoma
  • A 65-year-old woman with steatorrhea, weight loss, new-onset diabetes mellitus, and incidentally discovered cholelithiasis; imaging reveals a solid pancreatic mass.Somatostatinoma

Cevap

1 matches with VIPoma, 2 matches with Glucagonoma, 3 matches with Carcinoid tumor, 4 matches with Gastrinoma, and 5 matches with Somatostatinoma.
Each clinical vignette highlights the pathognomonic features of a specific functioning neuroendocrine tumor. VIPoma leads to WDHA syndrome (Watery Diarrhea, Hypokalemia, Achlorhydria). Glucagonoma is characterized by necrolytic migratory erythema, diabetes, and weight loss. Carcinoid tumor secretes serotonin, causing episodic flushing, diarrhea, and right-sided heart valve fibrosis (tricuspid regurgitation). Gastrinoma causes Zollinger-Ellison syndrome with severe, refractory peptic ulcer disease and is highly associated with MEN1 (evidenced by primary hyperparathyroidism). Somatostatinoma causes generalized inhibition of GI function, leading to steatorrhea (decreased pancreatic enzymes), cholelithiasis (decreased gallbladder contraction), and diabetes (decreased insulin).

Adım Adım Çözüm

1
Analyze each vignette for the predominant clinical syndrome, specifically noting fluid/electrolyte shifts, skin findings, cardiac murmurs, or ulcer characteristics.
Identified specific combinations of systemic symptoms indicating hormone overproduction.
Neuroendocrine tumors are diagnosed clinically by their functional syndromes before biochemical or imaging confirmation is sought.
2
Correlate the identified clinical syndrome with the corresponding gastrointestinal or pancreatic hormone.
Matched WDHA to VIP, necrolytic migratory erythema to Glucagon, flushing/tricuspid regurgitation to Serotonin, MEN1/refractory ulcers to Gastrin, and the inhibitory triad (stones, steatorrhea, diabetes) to Somatostatin.
Each tumor type originates from distinct endocrine cells (e.g., alpha cells, delta cells, enterochromaffin cells) with specialized secretory profiles.

Anahtar Kavram

Clinical recognition of functional gastrointestinal and pancreatic neuroendocrine tumors based on their characteristic hormone hypersecretion syndromes.
Tahmini Süre:2m 0s
Bu soruyu puanla

Konular

Gastroenterology and Hepatology

Bu konudan daha fazla soru